Exagen (XGN) Cash from Financing Activities (2018 - 2026)

Exagen (XGN) has 9 years of Cash from Financing Activities data on file, last reported at -$62000.0 in Q1 2026.

• Quarterly Cash from Financing Activities rose 3.12% year-over-year to -$62000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.4 million (up 3997.45% YoY) and the FY2025 annual result came in at $24.4 million, up 3785.52% from the prior year.
• Cash from Financing Activities improved to -$62000.0 in Q1 2026, from -$384000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $21.9 million in Q2 2025 to a low of -$10.2 million in Q2 2023.
• A 5-year average of $740529.4 and a median of -$108000.0 in 2023 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities plunged 3779.55% — and 2025, when it surged 9804.87%.
• Tracing XGN's Cash from Financing Activities over 5 years: stood at -$173000.0 in 2022, then retreated by 27.17% to -$220000.0 in 2023, then increased by 1.82% to -$216000.0 in 2024, then tumbled by 77.78% to -$384000.0 in 2025, then soared by 83.85% to -$62000.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$62000.0 (Q1 2026), -$384000.0 (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.